Viewing StudyNCT00616564



Ignite Creation Date: 2024-05-05 @ 7:10 PM
Last Modification Date: 2024-10-26 @ 9:44 AM
Study NCT ID: NCT00616564
Status: COMPLETED
Last Update Posted: 2012-05-03
First Post: 2008-02-04

Brief Title: Phase II Trial of IL-2 With Priming and GM-CSF in Patients With Advanced Melanoma
Sponsor: Mt Sinai Medical Center Miami
Organization: Mt Sinai Medical Center Miami

Conditions & Keywords Data

Conditions:
Name
Malignant Melanoma
Keywords:
Name View
Sargrostim View
GM-CSF View
Interleukin View
IL-2 View